References
- . Woo EY, Yeh H, Chu CS, . Cutting edge: regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J Immunol. 2002;168(9):4272–1276
- . Disis ML, West HL, Schiffman K. Cancer vaccines for the treatment and prevention of non-small cell lung cancer. Clin Lung Cancer. 2000;1(4):294–301
- . Salgaller ML. The development of immunotherapies for non-small cell lung cancer. Expert Opin Biol Ther. 2002;2(3):265–278
- . Rook AH, Kehrl JH, Wakefield LM, . Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J Immunol. 1986;136(10):3916–3920
- . Tsunawaki S, Sporn M, Ding A, Nathan C. Deactivation of macrophages by transforming growth factor-beta. Nature. 1988;334(6179):260–262
- . Naganuma H, Sasaki A, Satoh E, . Transforming growth factor-beta inhibits interferongamma secretion by lymphokine-activated killer cells stimulated with tumor cells. Neurol Med Chir (Tokyo). 1996;36(11):789–795
- . Fakhrai H, Mantil JC, Liu L, . Phase I clinical trial of TGF-beta antisense-modified tumor cell vaccine in patients with advanced glioma. Cancer Gene Ther. 2006;13(12):1052–1060